Stability of Human-Milk Oligosaccharide Concentrations Over 1 Week of Lactation and Over 6 Hours Following a Standard Meal.


Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
14 01 2023
Historique:
received: 13 04 2022
revised: 07 07 2022
accepted: 09 09 2022
pubmed: 17 9 2022
medline: 18 1 2023
entrez: 16 9 2022
Statut: ppublish

Résumé

Our previous studies revealed that human-milk oligosaccharides (HMOs) have health benefits for nursing infants and their concentrations change dynamically over 24 mo of lactation. Yet, the extent to which HMOs vary over the short term (days) and in response to acute factors such as maternal diet is unclear. The purpose of this study was to determine the stability of HMO concentrations over 7 d and in response to a standard meal and sugar-sweetened beverage (SSB) over 6 h. In this ancillary study, lactating mothers were enrolled at 6 wk postpartum. Participants received in-person instructions and materials to complete procedures at home. In the 1-wk experiment (n = 11), mothers pumped a milk sample at 07:00 h for 7 consecutive days. In the 6-h experiment (n = 35), mothers pumped a milk sample after an overnight fast at 06:00 h and then consumed a standard meal plus SSB provided by the study team. Mothers pumped a milk sample every hour for 6 consecutive hours. Samples were analyzed for the 19 most abundant HMOs. Repeated-measures ANOVA was used to test changes in HMO concentrations over time, reported as F(dftime, dferror) = F value, P value. Concentrations of all assayed HMOs were stable over 7 consecutive days, including, for example, the most widely studied HMOs in relation to infant health: 2'-fucosyllactose (2'FL) [F(2,17) = 0.39, P = 0.65], disialyl-lacto-N-tetraose (DSLNT) [F(4, 37) = 0.60, P = 0.66], and lacto-N-neotetraose (LNnT) [F(3, 32) = 1.5, P = 0.23]. Concentrations of all assayed HMOs were stable in response to a standard meal plus SSB. For example, fasted baseline concentrations of 2'FL, DSLNT, and LNnT were 2310 ± 1620 μg/mL, 560 ± 290 μg/mL, and 630 ± 290 μg/mL, respectively, and there were no changes in 2'FL [F(4, 119) = 1.9, P = 0.13], DSLNT [F(4, 136) = 0.39, P = 0.83], and LNnT [F(4, 120) = 0.64, P = 0.63] over 6 consecutive hours. HMO concentrations are stable over 1 wk of lactation and are not acutely affected by a standard meal plus SSB in mothers.

Sections du résumé

BACKGROUND
Our previous studies revealed that human-milk oligosaccharides (HMOs) have health benefits for nursing infants and their concentrations change dynamically over 24 mo of lactation. Yet, the extent to which HMOs vary over the short term (days) and in response to acute factors such as maternal diet is unclear.
OBJECTIVE
The purpose of this study was to determine the stability of HMO concentrations over 7 d and in response to a standard meal and sugar-sweetened beverage (SSB) over 6 h.
METHODS
In this ancillary study, lactating mothers were enrolled at 6 wk postpartum. Participants received in-person instructions and materials to complete procedures at home. In the 1-wk experiment (n = 11), mothers pumped a milk sample at 07:00 h for 7 consecutive days. In the 6-h experiment (n = 35), mothers pumped a milk sample after an overnight fast at 06:00 h and then consumed a standard meal plus SSB provided by the study team. Mothers pumped a milk sample every hour for 6 consecutive hours. Samples were analyzed for the 19 most abundant HMOs. Repeated-measures ANOVA was used to test changes in HMO concentrations over time, reported as F(dftime, dferror) = F value, P value.
RESULTS
Concentrations of all assayed HMOs were stable over 7 consecutive days, including, for example, the most widely studied HMOs in relation to infant health: 2'-fucosyllactose (2'FL) [F(2,17) = 0.39, P = 0.65], disialyl-lacto-N-tetraose (DSLNT) [F(4, 37) = 0.60, P = 0.66], and lacto-N-neotetraose (LNnT) [F(3, 32) = 1.5, P = 0.23]. Concentrations of all assayed HMOs were stable in response to a standard meal plus SSB. For example, fasted baseline concentrations of 2'FL, DSLNT, and LNnT were 2310 ± 1620 μg/mL, 560 ± 290 μg/mL, and 630 ± 290 μg/mL, respectively, and there were no changes in 2'FL [F(4, 119) = 1.9, P = 0.13], DSLNT [F(4, 136) = 0.39, P = 0.83], and LNnT [F(4, 120) = 0.64, P = 0.63] over 6 consecutive hours.
CONCLUSIONS
HMO concentrations are stable over 1 wk of lactation and are not acutely affected by a standard meal plus SSB in mothers.

Identifiants

pubmed: 36111739
pii: S0022-3166(23)08661-3
doi: 10.1093/jn/nxac214
pmc: PMC9839992
doi:

Substances chimiques

Oligosaccharides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2727-2733

Subventions

Organisme : NICHD NIH HHS
ID : R00 HD098288
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK110793
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD080444
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Références

Obesity (Silver Spring). 2020 Aug;28(8):1519-1525
pubmed: 32935530
Pediatr Obes. 2017 Apr;12(2):171-178
pubmed: 26956226
J Nutr. 1986 May;116(5):881-6
pubmed: 3701463
Int J Mol Sci. 2022 Mar 03;23(5):
pubmed: 35269946
Adv Nutr. 2012 May 01;3(3):383S-91S
pubmed: 22585916
Front Pediatr. 2018 Jul 24;6:197
pubmed: 30140664
Am J Clin Nutr. 2015 Dec;102(6):1381-8
pubmed: 26511224
J Biol Chem. 2005 Feb 11;280(6):4228-37
pubmed: 15557321
Sci Rep. 2020 Dec 16;10(1):22092
pubmed: 33328537
Front Pediatr. 2019 Jul 18;7:297
pubmed: 31380329
J Nutr. 2018 Nov 1;148(11):1733-1742
pubmed: 30247646
Sci Rep. 2019 Aug 13;9(1):11767
pubmed: 31409852
Nutrients. 2020 Mar 17;12(3):
pubmed: 32192176
JAMA Pediatr. 2013 Sep;167(9):836-44
pubmed: 23896931
Ann Hum Biol. 2021 Sep;48(6):455-465
pubmed: 35105200
Annu Rev Nutr. 2009;29:177-222
pubmed: 19575597
Acta Paediatr Suppl. 1999 Aug;88(430):89-94
pubmed: 10569230
Curr Dev Nutr. 2020 Jul 02;4(8):nzaa113
pubmed: 32734137
Am J Clin Nutr. 2007 Feb;85(2):561-9
pubmed: 17284758
Glycobiology. 2006 Jun;16(6):477-87
pubmed: 16495330
PLoS One. 2020 Feb 12;15(2):e0228323
pubmed: 32049968
J Biol Chem. 2020 Mar 20;295(12):4035-4048
pubmed: 32014993
Glycobiology. 2012 Sep;22(9):1147-62
pubmed: 22513036
Adv Nutr. 2012 May 01;3(3):392S-7S
pubmed: 22585917
Nutrients. 2018 May 24;10(6):
pubmed: 29795005
Br J Nutr. 2010 Nov;104(9):1261-71
pubmed: 20522272
J Nutr. 2021 Apr 8;151(4):876-882
pubmed: 33693851
Am J Clin Nutr. 2019 Sep 1;110(3):769-779
pubmed: 31274142
JAMA. 2001 May 16;285(19):2461-7
pubmed: 11368698
Breastfeed Med. 2017 Sep;12(7):390-395
pubmed: 29624432
Nutrients. 2021 Jun 08;13(6):
pubmed: 34201331

Auteurs

Paige K Berger (PK)

Department of Pediatric Newborn Medicine, Mass General Brigham, Harvard Medical School, Boston, MA, USA.

Hailey E Hampson (HE)

Department of Pediatrics, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Kelsey A Schmidt (KA)

Department of Pediatrics, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Tanya L Alderete (TL)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO, USA.

Annalee Furst (A)

Department of Pediatrics and Mother-Milk-Infant Center of Research Excellence (MOMI CORE), University of California, San Diego, La Jolla, CA, USA.

Chloe Yonemitsu (C)

Department of Pediatrics and Mother-Milk-Infant Center of Research Excellence (MOMI CORE), University of California, San Diego, La Jolla, CA, USA.

Ellen Demerath (E)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.

Michael I Goran (MI)

Department of Pediatrics, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.

David A Fields (DA)

Department of Pediatrics, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Lars Bode (L)

Department of Pediatrics and Mother-Milk-Infant Center of Research Excellence (MOMI CORE), University of California, San Diego, La Jolla, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH